You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 5, May 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (36)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ophthalmology, Other
 •Alert me on articles by topic

Activated Protein C Resistance, Factor V Leiden, and Central Retinal Vein Occlusion in Young Adults

Justin L. Gottlieb, MD; Jeffrey P. Blice, MD; Bernadette Mestichelli, BS, MT(ASCP); Barbara A. Konkle, MD; William E. Benson, MD

Arch Ophthalmol. 1998;116:577-579.

Objective  To confirm the relationship between resistance to activated protein C (APC), factor V Leiden, and central retinal vein occlusion in young adults as reported in a recent study of patients younger than 50 years.

Patients and Methods  Patients younger than 50 years with central retinal vein occlusion were identified from the medical records of the Wills Eye Hospital Retina and Retina Vascular Services. Blood samples were taken from each patient and analyzed for resistance to APC and identification of factor V Leiden.

Results  Only 1 (4.7%) of 21 patients evidenced resistance to APC and the presence of factor V Leiden. This patient was also the only one to report a family history of thrombotic disease.

Conclusions  We were unable to confirm the high percentage of resistance to ACP among young adult patients with central retinal vein occlusion. The finding of resistance to APC in only 1 (4.7%) of 21 patients is similar to that found in the general population.


From the Retina Service of Wills Eye Hospital (Drs Gottlieb, Blice, and Benson) and the Cardeza Foundation for Hematologic Research, Department of Medicine, Thomas Jefferson University (Ms Mestichelli and Dr Konkle), Philadelphia, Pa. Dr Gottlieb is now with the Department of Ophthalmology and Visual Science, University of Wisconsin, Madison.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The 15-Year Cumulative Incidence of Retinal Vein Occlusion: The Beaver Dam Eye Study
Klein et al.
Arch Ophthalmol 2008;126:513-518.
ABSTRACT | FULL TEXT  

Retinal Signs and Stroke: Revisiting the Link Between the Eye and Brain
Baker et al.
Stroke 2008;39:1371-1379.
ABSTRACT | FULL TEXT  

Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion
Hvarfner et al.
Br. J. Ophthalmol. 2003;87:305-306.
ABSTRACT | FULL TEXT  

Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease
CHAK et al.
Br. J. Ophthalmol. 2001;85:883-886.
FULL TEXT  

Heritable Thrombophilia and Hypofibrinolysis: Possible Causes of Retinal Vein Occlusion
Glueck et al.
Arch Ophthalmol 1999;117:43-49.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.